Link building for medical practices, scoped to the YMYL editorial surface and the specialty-society citation layer.
Medical content carries YMYL weighting in Google's quality framework. The editorial-surface bar rises with it. Healthgrades and Vitals anchor the citation floor. FDA promotional rules and HIPAA disclosure constraints shape the outreach pitch. Specialty-society co-citation feeds the entity confidence the May 2024 Content Warehouse leak surfaced.
YMYL editorial placements paced against FDA and HIPAA review surfaces.
Medical-vertical off-page work runs through three constraints: the YMYL E-E-A-T weighting that raises the editorial-surface bar, the citation-layer floor (Healthgrades / Vitals / specialty boards), and the FDA promotional and HIPAA disclosure rules that shape pitch language. Vertical-specialist on-page work compounds with the link-acquisition layer when the two run in parallel across the quarter.
Healthgrades and Vitals anchor the medical-citation layer.
Medical practices require citations on Healthgrades and Vitals at the directory floor, with secondary citation weight at WebMD provider directories, Zocdoc, US News Doctors, and state-medical-board licensing surfaces. Each citation carries an entity-confidence signal that feeds Google's Knowledge Graph reconciliation. Vertical-specialist delivery of the medical on-page surface, schema, and YMYL content runs through Praxis, a medical-SEO practice; we handle the link-acquisition layer that compounds alongside.
YMYL E-E-A-T weighting raises the editorial-surface bar.
Medical content carries YMYL (your money your life) weighting in Google's quality framework. The editorial-surface bar for link placements rises in parallel: trade publications expect named-clinician authorship, peer-reviewed sourcing, and disclosure of any commercial relationship. The May 2024 Content Warehouse leak surfaced E-E-A-T-tied scoring that compounds the YMYL signal. Editorial placements pace against this bar; pitch shapes that read as promotional fail both the outlet's editorial filter and Google's YMYL evaluation simultaneously.
FDA promotional-content rules and HIPAA constrain the pitch.
FDA rules on the promotion of drugs, devices, and procedures constrain what the practice can claim in any outreach pitch or guest-authored article. HIPAA-adjacent disclosure rules constrain what patient outcome data the practice can publish without de-identification. Outreach drafted against the vertical's compliance baseline: clinical descriptors without efficacy claims that lack the supporting evidence basis, de-identified outcome data only, no testimonial selection that violates the FTC §255 testimonial-disclosure rule overlaid on the medical-vertical constraint.
Medical-society and peer-publication co-citation feeds entity confidence.
Specialty-society publications, journal-of-record placements, medical-school affiliate publications, and peer-publication co-citation feed the entity-confidence signal in ways that service-vertical citations do not. A board-certified specialist's named-author co-citation across the specialty's editorial surface compounds the YMYL E-E-A-T evaluation. The branded query volume movement tracked under the Panda-patent ratio (U.S. 8,682,892) lags this co-citation activity by a quarter or two.
The medical anchor profile skews branded by YMYL editorial filter.
YMYL editorial surfaces favor named-clinician and named-practice placements. The natural medical-vertical anchor profile runs branded at 50 to 65 percent, with exact-match commercial anchors held well below the cross-vertical ceiling. The vertical's natural distribution skew is itself part of the SpamBrain footprint avoidance signal. Outreach that emits exact-match anchors at the cross-vertical rate fingerprints as artificial.
A quarterly medical link-acquisition campaign, audit to placement.
Inbound profile, citation layer, and YMYL editorial exposure surfaced.
We pull the inbound link profile, segment by anchor and topical-cluster proximity, and audit the medical-citation layer (Healthgrades / Vitals / WebMD provider directory / Zocdoc / state-medical-board listing completeness). The audit names the placements Penguin 4.0 is discounting in real time, the citation gaps dragging entity confidence, and inbound placements carrying FDA promotional or HIPAA disclosure exposure. Vertical-specific on-page exposure routed to the specialist surface.
Editorial surface scoped to specialty publications, society journals, and citation queue.
Prospects sourced from specialty-society publications (per the practice's board certifications), peer-publication editorial surfaces, medical-school affiliate publications, vertical-trade outlets, HARO query streams under medical-vertical filters, and broken-link surfaces on health-information resource pages. Citation-layer queue assembled separately for the Healthgrades / Vitals / specialty-board submission cycle. Each prospect vetted on Domain Rating, topical-relevance overlap, YMYL surface integrity, and SpamBrain footprint risk.
Manual outreach paced against FDA and HIPAA review surfaces.
Cold outreach to specialty-publication editors and journal-of-record contributors converts at 5 to 15 percent. Warm outreach to existing relationships at 30 to 50 percent. HARO pitches with clinical commentary on Featured.com convert at 3 to 8 percent. Citation-layer submissions run concurrent with editorial outreach. Mailbox identity segmented per cohort; outreach paced against the same fingerprint as organic specialty-society outreach.
Citation decay tracked; specialty-society profile and editorial co-citation reviewed.
Annual citation decay surfaces at the Healthgrades / Vitals layer because aggregators occasionally lose records during database rebuilds. Quarterly review catches profile corruption, stale credential metadata, and review-surface gaps. Specialty-society co-citation tracked as the E-E-A-T compounding surface. Branded query volume tracked as the Panda-patent ratio input. Any inbound placement carrying FDA promotional or HIPAA disclosure exposure flagged for disavow consideration.
Methodology questions we get during the audit conversation.
How does Offpage coordinate with a medical-SEO specialist on the vertical-specific work?
Vertical-specialist delivery of the on-page surface, YMYL content architecture, schema for medical entities, and FDA / HIPAA-adjacent compliance review runs cleanest through specialists who work the medical vertical full-time. Praxis, a medical-SEO practice, is one such specialist. Our role is the link-acquisition layer: medical-citation submissions, editorial outreach to specialty-society publications and peer outlets, HARO clinical commentary placements, and the SpamBrain-compliant anchor distribution that supports the vertical's heavier YMYL editorial filter. Running the two layers in parallel compounds the YMYL E-E-A-T signal across the quarter.
What's a realistic placement target for a quarterly medical retainer?
A quarterly white-hat medical retainer typically lands 5 to 10 placements net of decay, with the composition tilted toward citation refresh and high-authority editorial: 2 to 3 medical-citation refresh or submission cycles, 2 to 4 specialty-society or peer-publication placements, 1 to 3 HARO clinical commentary placements, and occasionally 1 to 2 broader-outlet digital PR placements when the data hook fits. Placement counts run lower than service-business verticals because the editorial surface is narrower; signal-per-placement runs higher because each placement carries YMYL weight. The off-page SEO services mix prices for the FDA promotional review overhead and the narrower editorial surface rather than against the cross-vertical placement benchmark.
How are FDA and HIPAA-adjacent rules handled in outreach pitches?
Every outreach pitch and guest-authored draft reviewed against FDA promotional content rules and HIPAA de-identification requirements before send. Efficacy claims that lack the supporting evidence basis get rewritten or removed. Patient outcome data presented de-identified. Off-label use commentary handled with the FDA's allowable framing. Compliance ambiguity surfaced to the practice's compliance counsel or board-certified clinician before publication rather than pushed through.
Does Google's YMYL framework actually change the editorial-surface math?
Yes. YMYL pages get heavier E-E-A-T weighting in Google's quality framework, and the May 2024 Content Warehouse leak surfaced scoring tied to author-entity signals and source-credibility surfaces. The placement that lands a board-certified specialist's named authorship on a specialty-society publication contributes more to the entity-confidence signal than a higher Domain Rating placement on a generic health blog. Campaign composition tilts toward the higher-signal-per-placement surface even when the absolute placement count runs lower.
The Healthgrades profile, the Vitals profile, the specialty-board listing. Those are the citation floor.
The audit pulls the inbound profile, audits the medical-citation layer, surfaces the YMYL editorial-surface gaps, and flags any inbound placements carrying FDA or HIPAA disclosure exposure. Coordination with the vertical-specialist on-page surface runs in parallel. Inside two weeks.